Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Vitamin B3, also known as niacin or niacinamide (nicotinamide), has some clinical and scientific basis for its use in supporting or treating peripheral neuropathy, although it is not as strongly validated as other B vitamins such as B1 (thiamine) or B12 (cobalamin). Peripheral neuropathy is nerve damage often linked to diabetes, alcohol abuse, or nutritional deficiencies. Historically, severe niacin deficiency leads to pellagra, which can present with neurological symptoms, but frank pellagra is rare in developed countries.

Some studies have shown that niacinamide may have neuroprotective effects and may help with nerve regeneration and repair, potentially reducing symptoms of peripheral neuropathy. For example, preclinical studies suggest that vitamin B3 can support nerve health, and there is limited evidence from small clinical trials indicating possible benefit in neuropathy associated with diabetes or chemotherapy. However, large, high-quality randomized controlled trials are lacking, and niacin or niacinamide is not considered a first-line treatment for peripheral neuropathy by major clinical guidelines. The primary B vitamins with established roles in neuropathy prevention and treatment are B1 (benfotiamine or thiamine), B6 (pyridoxine, with caution), and B12.

In summary, while there is some scientific rationale and limited supporting evidence for the use of vitamin B3 in peripheral neuropathy, the evidence is moderate at best, and it is not the primary or most validated B vitamin for this condition.

More about Vitamin B3 (mixed)
More about Peripheral Neuropathy

Other ingredients used for Peripheral Neuropathy

Other health conditions supported by Vitamin B3 (mixed)

Products containing Vitamin B3 (mixed)